← Back to Discover
Johnson & Johnson Innovation - JJDC, Inc.
Period ended Jun 30, 2021 · Latest filing Aug 3, 2021
These quarterly holdings are delayed and may not include all assets or short positions.
Values are from the reporting date, not current prices or purchase costs.
The same security may appear in multiple rows.
Source: SEC
Reported portfolio value
Quarter-end reported holdings; not current value or investment performance.
View reported values
- Jun 30, 2021: $978,187,000
More quarters will appear as history becomes available.
Top holdings
Top 10 at Jun 30, 2021. Matching entries are combined; security classes and options remain separate. Shares exclude principal amounts; option shares reflect the reported underlying amount.
View top holdings values
- FATE THERAPEUTICS, INC. · COM · 31189P102 · shares: $293,269,000
- ARROWHEAD PHARMACEUTICALS · COM · 04280A100 · shares: $270,065,000
- PROTAGONIST THERAPEUTICS INC. · COM · 74366E102 · shares: $109,919,000
- CVRX, INC. · COM · 126638105 · shares: $97,876,000
- LEGEND BIOTECH CORPORATION · SPONSORED ADS · 52490G102 · shares: $66,878,000
- MEIRAGTX HOLDINGS PLC · COM · G59665102 · shares: $44,928,000
- FUSION PHARMACEUTICALS INC. · COM · 36118A100 · shares: $29,658,000
- VOR BIOPHARMA, INC. · COM · 929033108 · shares: $20,042,000
- BIOMX INC. · COM · 09090D103 · shares: $11,648,000
- THERAPEUTICS ACQUISITION COR · COM CL A · 88339T103 · shares: $10,274,000
Reported holdings
21 reported entries| Issuer | Class | CUSIP | Type | Shares / principal | Reported value (USD) |
|---|---|---|---|---|---|
| FATE THERAPEUTICS, INC. | COM | 31189P102 | — | 3,379,064 shares | $293,269,000 |
| ARROWHEAD PHARMACEUTICALS | COM | 04280A100 | — | 3,260,869 shares | $270,065,000 |
| PROTAGONIST THERAPEUTICS INC. | COM | 74366E102 | — | 2,449,183 shares | $109,919,000 |
| CVRX, INC. | COM | 126638105 | — | 3,495,575 shares | $97,876,000 |
| LEGEND BIOTECH CORPORATION | SPONSORED ADS | 52490G102 | — | 1,629,173 shares | $66,878,000 |
| MEIRAGTX HOLDINGS PLC | COM | G59665102 | — | 2,898,550 shares | $44,928,000 |
| FUSION PHARMACEUTICALS INC. | COM | 36118A100 | — | 3,670,516 shares | $29,658,000 |
| VOR BIOPHARMA, INC. | COM | 929033108 | — | 1,074,658 shares | $20,042,000 |
| BIOMX INC. | COM | 09090D103 | — | 2,133,402 shares | $11,648,000 |
| THERAPEUTICS ACQUISITION COR | COM CL A | 88339T103 | — | 1,000,000 shares | $10,274,000 |
| ADICET BIO, INC. | COM | 007002108 | — | 728,944 shares | $7,501,000 |
| PHASEBIO PHARMACEUTICALS, INC. | COM | 717224109 | — | 1,607,044 shares | $5,978,000 |
| ALDEYRA THERAPEUTICS, INC. | COM | 01438T106 | — | 394,834 shares | $4,473,000 |
| CASTLIGHT HEALTH INC. | CL B | 14862Q100 | — | 811,295 shares | $2,134,000 |
| NEUROPACE, INC. | COM | 641288105 | — | 55,435 shares | $1,319,000 |
| ZYMERGEN INC. | COM | 98985X100 | — | 16,553 shares | $662,000 |
| TRACON PHARMACEUTICALS, INC. | COM | 89237H209 | — | 84,003 shares | $545,000 |
| CATALYST BIOSCIENCES, INC. | COM | 14888D208 | — | 66,951 shares | $290,000 |
| GRAYBUG VISION, INC. | COM SHS | 38942Q103 | — | 49,547 shares | $269,000 |
| PULMONX CORPORATION | COM | 745848101 | — | 5,639 shares | $249,000 |
| SENSEONICS HOLDINGS, INC. | COM | 81727U105 | — | 54,621 shares | $210,000 |